Alvotech and advanz pharma extend strategic partnership to commercialize five proposed biosimilars in europe

Alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and advanz pharma, a uk headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in europe, today announced that the companies have entered into an exclusive partnership agreement regarding the supply and commercialization of five biosimilar candidates in europe.  alvotech will be responsible for development and commercial supply and advanz pharma will be responsible for registration and commercialization in europe.
ALVO Ratings Summary
ALVO Quant Ranking